Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
1 min read
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a prescription, a wearable sensor and an app. Today, a new FDA designation gets the company one step closer to that goal. Founded in…